5Russell RG, Watts NB, Ebetino FH, et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influ- ence on clinical efficacy [J]. Osteoporos Int, 2009, 19 (6) : 733 - 759.
6Lakatos P,Takacs I,Marton I,et al.A retrospective longitudinal database study of persistence and compliance with treatment of osteoporosis in hungary[J].Calcif Tissue Int,2015,22(6):109-113.
7Zhang Y,Feng E,Xu Y,et al.Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis[J].Int J Clin Exp Med,2015,8(9):16352-16357.
8Ma M,Chen X,Lu L,et al.Identification of crucial genes related to postmenopausal osteoporosis using gene expression profiling[J].Aging Clin Exp Res,2015,23(8):123-126.
9Modi A,Sen S,Adachi JD,et al.Gastrointestinal symptoms and association with medication use patterns,adherence,treatment satisfaction,quality of life,and resource use in osteoporosis:baseline results of the MUSIC-OS study[J].Osteoporos Int,2015,33(5):133-134.
